Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Schett
Steven L Teitelbaum

Showing results (81-90 of 1,160) with videos related to

Pageof 116
Sort By:
Bone Research|August 15, 2015
Osteoclasts: New InsightsXu Feng, Steven L Teitelbaum
The New England Journal of Medicine|December 14, 2011
The pathogenesis of rheumatoid arthritisIain B McInnes, Georg Schett
Annals of the Rheumatic Diseases|May 5, 2022
Sequential interleukin-17/interleukin-23 inhibition in treatment-refractory psoriatic arthritisDavid Simon, Filippo Fagni, Georg Schett
Annals of the Rheumatic Diseases|October 19, 2014
The impact of rheumatoid factor and ACPA on bone erosion in rheumatoid arthritisCarolin Hecht, Georg Schett, Stephanie Finzel
The New England Journal of Medicine|May 1, 2024
CAR T-Cell Therapy in Autoimmune Disease. ReplyFabian Müller, Andreas Mackensen, Georg Schett
The Lancet. Neurology|May 17, 2024
B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseasesAiden Haghikia, Georg Schett, Dimitrios Mougiakakos
EULAR Rheumatology Open|June 29, 2026
Editorial-Immune reset in sight: CAR-T cell therapy in autoimmune diseaseMelanie Hagen, Georg Schett, Andreas Wirsching
The New England Journal of Medicine|November 27, 2009
Denosumab, osteoporosis, and prevention of fracturesStefan Kiechl, Johann Willeit, Georg Schett
Seminars in Arthritis and Rheumatism|November 20, 2015
Adult onset Still's disease associated with malignancy-Cause or coincidence?Katharina Hofheinz, Georg Schett, Bernhard Manger
Autoimmunity|May 23, 2007
The lonely death: chondrocyte apoptosis in TNF-induced arthritisKarin Polzer, Georg Schett, Jochen Zwerina
Pageof 116

Showing results (81-90 of 1,160) with videos related to

Sort By:
Pageof 116
Bone Research|August 15, 2015
Osteoclasts: New InsightsXu Feng, Steven L Teitelbaum
The New England Journal of Medicine|December 14, 2011
The pathogenesis of rheumatoid arthritisIain B McInnes, Georg Schett
Annals of the Rheumatic Diseases|May 5, 2022
Sequential interleukin-17/interleukin-23 inhibition in treatment-refractory psoriatic arthritisDavid Simon, Filippo Fagni, Georg Schett
Annals of the Rheumatic Diseases|October 19, 2014
The impact of rheumatoid factor and ACPA on bone erosion in rheumatoid arthritisCarolin Hecht, Georg Schett, Stephanie Finzel
The New England Journal of Medicine|May 1, 2024
CAR T-Cell Therapy in Autoimmune Disease. ReplyFabian Müller, Andreas Mackensen, Georg Schett
The Lancet. Neurology|May 17, 2024
B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseasesAiden Haghikia, Georg Schett, Dimitrios Mougiakakos
EULAR Rheumatology Open|June 29, 2026
Editorial-Immune reset in sight: CAR-T cell therapy in autoimmune diseaseMelanie Hagen, Georg Schett, Andreas Wirsching
The New England Journal of Medicine|November 27, 2009
Denosumab, osteoporosis, and prevention of fracturesStefan Kiechl, Johann Willeit, Georg Schett
Seminars in Arthritis and Rheumatism|November 20, 2015
Adult onset Still's disease associated with malignancy-Cause or coincidence?Katharina Hofheinz, Georg Schett, Bernhard Manger
Autoimmunity|May 23, 2007
The lonely death: chondrocyte apoptosis in TNF-induced arthritisKarin Polzer, Georg Schett, Jochen Zwerina
Pageof 116